Health News Releases

June 30, 13:50

Cartilage Tissue Engineering Heads to Orbit in NSF and NASA-supported Study at the International Space Station

Researchers in the DELTAi Lab at the University of California, Irvine (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fsites.uci.edu%2Fdeltai%2F&esheet=54561327&newsitemid=2026062954

June 29, 09:34

DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion followin

June 28, 14:55

Burjeel Holdings Prices First MENA Healthcare Sukuk Since 2018, 3.2x Oversubscribed

The offering attracted significant demand from high-quality international and regional investors, with the orderbook peaking at USD 1.6 billion, representing 3.2x oversubscription. The strength of the

June 26, 11:30

MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b

MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, today announced the appointment of two experienced industry leaders to its Board of Directors a

June 24, 16:32

Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO

In the final step of its 18-month CEO transition, Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&eshee

June 24, 08:51

Merck Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies

Merck, a leading global science and technology company, today announced a strategic research-stage collaboration with Saturnus Bio, a Versant Ventures-founded biotech, aimed at establishing a foundati

June 23, 11:30

HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors

HistoSonics (https://histosonics.com/?utm_source=chatgpt.com), the developer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the closing of a new financing r

June 22, 14:00

CellFiber to Co-Host Next-Generation Stem Cell Manufacturing and Commercialization Workshop with Cytiva in Korea

CellFiber will jointly host the Next-Generation Stem Cell Manufacturing and Commercialization Strategy Workshop with Cytiva on Wednesday, 15 July 2026 at the Cytiva APAC Fast Trak™ Center in Songdo, I

June 19, 11:01

Astrogen, inc. Validates Autism Spectrum Disorder Research with Prestigious Folia Award

Astrogen, inc. (https://astrogen.co.kr/eng/index.html), a leading biotech company in South Korea, said that it has received the “Folia Award (https://onlinelibrary.wiley.com/doi/toc/10.1111/) (ISSN)14

June 17, 15:55

BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit

BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chro

June 17, 11:30

Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Drug Discovery

Biocytogen today announced that its Boston research facility has been awarded Full Accreditation by AAALAC International, a globally recognized organization dedicated to promoting excellence in labora

June 16, 16:55

New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54552126&newsitemid=20260615651327&lan=en-US&ancho

June 16, 08:55

SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (

June 15, 16:45

Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI

India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the

June 15, 11:10

BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026

BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 E

June 12, 16:50

Roquette Showcases Scalable Drug Delivery Innovations at CPHI China 2026

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, will showcase its comprehensive portfolio of innovative drug delivery solutions at CPHI & PMEC China 2026, taking pl

June 12, 15:20

Parse Biosciences Launches the Next Generation of its Immune Profiling Kits

Parse Biosciences (https://www.parsebiosciences.com/), the leading provider of scalable and accessible single cell sequencing solutions, today launched the next generation of its Evercode™ TCR (https:

June 12, 15:10

Merrithew® Expands Global Mindful Movement Leadership with Acquisition of the GYROTONIC® Organization

Merrithew®, a global leader in mindful movement education and equipment and creator of internationally recognized programs including STOTT PILATES®, ZEN·GA®, Halo® Training and Total Barre®, today ann

June 12, 11:20

Cosylab and Heron Neutron Medical Corp. Sign Letter of Intent to Advance Global Deployment of Accelerator-Based BNCT Systems

Cosylab and Heron Neutron Medical Corp. announced today, 10 June 2026, the signing of a Letter of Intent to establish a strategic framework for joint market development to support the global deploymen

June 12, 10:51

Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279),

June 11, 14:45

Galderma Unveils New Global Survey Data Exploring the Evolving Expectations and Experiences of Patients and Healthcare Professionals With Anti-wrinkle Treatments

Galderma (SIX: GALD) has released findings from a landmark global survey conducted across the United States (U.S.), Brazil, the United Kingdom (UK), and China - the largest of its kind - exploring the

June 10, 16:45

New Polymorph of Indomethacin Discovered

Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), announced tha

June 10, 15:00

New Study Reveals the True Environmental Impact of Periodontal Disease - And What You Can Do About It

Today P&G Oral Care announces the release of a new, first-of-its kind LCA study published in the Journal of Dentistry finds managing advanced periodontal disease can be associated with up to ~10× high